<DOC>
	<DOCNO>NCT01210716</DOCNO>
	<brief_summary>This study evaluate use AMICUS device patient Therapeutic Plasma Exchange ( TPE ) prescribe physician .</brief_summary>
	<brief_title>Evaluation Therapeutic Plasma Exchange ( TPE ) Procedure Using AMICUS Device</brief_title>
	<detailed_description>Therapeutic plasma exchange ( TPE ) intend efficient removal circulate plasma , return replacement fluid patient . In majority case , treatment goal selectively remove substance directly responsible patient 's disease process . Fenwal 's AMICUS separator platform centrifuge-based apheresis system collect blood component interest return remain blood component along saline back donor/patient . The device clear follow : - The collection platelet plasma Japan , Europe US ( BK960005 ) , 1996 . - The collection mononuclear cell ( MNCs ) US ( BK000047 ) , 2002 . - The collection concurrent red blood cell ( cRBC ) product collect ACD-A anticoagulant store ADSOLÂ® Preservation Solution ( BK000039 ) , 2002 . Fenwal develop new protocol AMICUS separator enables device perform TPE procedure . The procedure similar FDA clear platelet concurrent plasma collection , except TPE procedure majority plasma retain red blood cell ( RBCs ) , white blood cell ( WBC ) majority platelet return patient .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Autoimmune Diseases</mesh_term>
	<mesh_term>Hematologic Diseases</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<criteria>1 . Medically stable patient undergo one TPE procedure provide sign informed consent prior participation . 2 . A physician 's prescription TPE various nonemergent condition . 3 . Test Control TPE procedure would expect complete within approximately five week . 1 . Patients 18 year old . 2 . Patients ACE inhibitor medication discontinue use medication accordance institutional practice . 3 . Patients alter mental status would prohibit give understand informed consent . 4 . Patients experience serious adverse event associate first TPE clinical study procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Therapeutic plasma exchange</keyword>
	<keyword>Autoimmune disease</keyword>
	<keyword>Kidney transplant</keyword>
	<keyword>Hematologic disorder</keyword>
	<keyword>Monoclonal gammopathy</keyword>
	<keyword>Neurologic disorder</keyword>
</DOC>